Oliver B - Search Results

1

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis.

Fadul CE, Mao-Draayer Y, Ryan KA, Noelle RJ, Wishart HA, Channon JY, Kasper IR, Oliver B, Mielcarz DW, Kasper LH. Fadul CE, et al. Among authors: oliver b. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 15;8(6):e1096. doi: 10.1212/NXI.0000000000001096. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34654708 Free PMC article. Clinical Trial.

2

Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials.

Oliver BJ, Kohli E, Kasper LH. Oliver BJ, et al. J Neurol Sci. 2011 Mar 15;302(1-2):96-105. doi: 10.1016/j.jns.2010.11.003. Epub 2010 Dec 16. J Neurol Sci. 2011. PMID: 21167504 Review.

3

Testing Feasibility of a Mobile Application to Monitor Fatigue in People With Multiple Sclerosis.

Newland P, Oliver B, Newland JM, Thomas FP. Newland P, et al. Among authors: oliver b. J Neurosci Nurs. 2019 Dec;51(6):331-334. doi: 10.1097/JNN.0000000000000479. J Neurosci Nurs. 2019. PMID: 31688283

4

System-Level Variation in Multiple Sclerosis Disease-Modifying Therapy Utilization: Findings From the Multiple Sclerosis Continuous Quality Improvement Research Collaborative.

N'Dri LA, Waters DD, Walsh K, Mehta F, Oliver BJ; MS-CQI Investigators. N'Dri LA, et al. Perm J. 2021 Dec 14;25:21.025. doi: 10.7812/TPP/21.025. Perm J. 2021. PMID: 35348092 Free PMC article.

5

Primary care management of fatigue and relapses in RRMS.

Oliver BJ. Oliver BJ. Nurse Pract. 2009 Sep;34(9):10-4. doi: 10.1097/01.NPR.0000360141.20313.d0. Nurse Pract. 2009. PMID: 19713814 No abstract available.

6

System-Level Variation in Multiple Sclerosis Care Outcomes: Initial Findings from the Multiple Sclerosis Continuous Quality Improvement Research Collaborative.

Oliver BJ, Walsh K, Messier R, Mehta F, Cabot A, Klawiter E, Pagnotta P, Solomon A, England SE. Oliver BJ, et al. Popul Health Manag. 2022 Feb;25(1):46-56. doi: 10.1089/pop.2021.0040. Epub 2021 Jun 16. Popul Health Manag. 2022. PMID: 34134513

7

Comparing traditional modeling approaches versus predictive analytics methods for predicting multiple sclerosis relapse.

Walsh K, Shah R, Armstrong JK, Moore ES, Oliver BJ. Walsh K, et al. Among authors: oliver bj. Mult Scler Relat Disord. 2022 Jan;57:103330. doi: 10.1016/j.msard.2021.103330. Epub 2021 Oct 17. Mult Scler Relat Disord. 2022. PMID: 35158444 Clinical Trial.

8

Contact patterns and costs of multiple sclerosis in the Swedish healthcare system-A population-based quantitative study.

Lind J, Persson S, Vincent J, Lindenfalk B, Oliver BJ, Smith AD 3rd, Andersson Gäre B. Lind J, et al. Among authors: oliver bj. Brain Behav. 2022 Jun;12(6):e2582. doi: 10.1002/brb3.2582. Epub 2022 May 5. Brain Behav. 2022. PMID: 35511113 Free PMC article.

9

Initial development of a self-assessment approach for coproduction value creation by an international community of practice.

Oliver BJ, Forcino RC, Batalden PB. Oliver BJ, et al. Int J Qual Health Care. 2021 Nov 29;33(Supplement_2):ii48-ii54. doi: 10.1093/intqhc/mzab077. Int J Qual Health Care. 2021. PMID: 34849960

10

Turning Feed-forward and Feedback Processes on Patient-reported Data into Intelligent Action and Informed Decision-making: Case Studies and Principles.

Oliver BJ, Nelson EC, Kerrigan CL. Oliver BJ, et al. Med Care. 2019 May;57 Suppl 5 Suppl 1:S31-S37. doi: 10.1097/MLR.0000000000001088. Med Care. 2019. PMID: 30985594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page